IR-Med, Inc. Announces the Resignation of Limor Davidson Mund as CEO and Appointment of Chairman of the Board Oded Bashan as Interim Chief Executive Officer

Rhea-AI Summary

IR-Med, Inc. (OTCPink: IRME) announced the resignation of CEO Limor Davidson Mund due to personal reasons. Mr. Oded Bashan, the current Chairman, is appointed as interim CEO. IR-Med is a development stage company focused on utilizing Infra-Red and Artificial Intelligence technologies for early detection of medical conditions such as pressure injuries and ear infections in children. This management change could provide new leadership perspectives as the company continues its development in the healthcare sector.

Positive

• Appointment of Oded Bashan as interim CEO may bring new leadership perspectives.

Negative

• Resignation of CEO may raise concerns about leadership continuity and experience.

New York, NY, April 08, 2021 (GLOBE NEWSWIRE) -- IR-Med, Inc, (OTCPink: IRME) (the “Company” or “IR-Med”) announced today the resignation of Limor Davidson Mund as Chief Executive Officer. Ms. Davidson Mund resigned for personal reasons.

Mr. Oded Bashan, the Company’s Chairman, has been appointed Chief Executive Officer on an interim basis.

About IR-Med

IR-Med is a development stage company currently focused on the development and application of Infra-Red (IR) and Artificial Intelligence (AI) technologies to address common medical ailments. Initially IR–Med’s technologies are designed to address the early detection of pressure injuries (PI) and the detection and diagnosis of ear infection, primarily in children. For more information visit http://www.ir-medical.com.

Company Contact: 

Sharon Levkoviz, CFO
sharon@ir-medical.com

FAQ

What happened in the recent IR-Med press release?

IR-Med announced the resignation of CEO Limor Davidson Mund, with Oded Bashan appointed as interim CEO.

Who is the new interim CEO of IR-Med?

Oded Bashan has been appointed as the interim CEO of IR-Med.

What is the reason for Limor Davidson Mund's resignation?

Limor Davidson Mund resigned from her position as CEO for personal reasons.

What technologies is IR-Med focused on?

IR-Med is focused on Infra-Red and Artificial Intelligence technologies for medical applications.

What impact could the management change have on IR-Med?

The management change may influence leadership direction and strategy as the company develops its healthcare technologies.